publication . Article . 2010

Selective estrogen receptor modulators as brain therapeutic agents

M. A. Arevalo; M. Santos-Galindo; N. Lagunas; I. Azcoitia; L. M. Garcia-Segura;
Open Access English
  • Published: 11 Nov 2010
  • Publisher: Society for Endocrinology
  • Country: Spain
Abstract
Selective estrogen receptor modulators (SERMs), used for the treatment of breast cancer, osteoporosis, and menopausal symptoms, affect the nervous system. Some SERMs trigger neuroprotective mechanisms and reduce neural damage in different experimental models of neural trauma, brain inflammation, neurodegenerative diseases, cognitive impairment, and affective disorders. New SERMs with specific actions on neurons and glial cells may represent promising therapeutic tools for the brain. © 2011 Society for Endocrinology.
Subjects
Medical Subject Headings: hormones, hormone substitutes, and hormone antagonists
free text keywords: Molecular Biology, Endocrinology, Osteoporosis, medicine.disease, medicine, Breast cancer, Nervous system, medicine.anatomical_structure, Cognitive impairment, Neuroprotection, Inflammation, medicine.symptom, Selective estrogen receptor modulators, Internal medicine, medicine.medical_specialty, Biology
Powered by OpenAIRE Open Research Graph
Any information missing or wrong?Report an Issue
publication . Article . 2010

Selective estrogen receptor modulators as brain therapeutic agents

M. A. Arevalo; M. Santos-Galindo; N. Lagunas; I. Azcoitia; L. M. Garcia-Segura;